BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36148239)

  • 1. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
    Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
    Front Immunol; 2022; 13():898799. PubMed ID: 36148239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers.
    Kang J; Liggett JR; Patil D; Ranjit S; Loh K; Duttargi A; Cui Y; Oza K; Frank BS; Kwon D; Kallakury B; Robson SC; Fishbein TM; Cui W; Khan K; Kroemer A
    Front Immunol; 2022; 13():899525. PubMed ID: 35833123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
    Zhu H; Zhang Q; Chen G
    Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury.
    Teoh NC; Williams J; Hartley J; Yu J; McCuskey RS; Farrell GC
    Hepatology; 2010 Mar; 51(3):996-1006. PubMed ID: 20131406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.
    Ellett JD; Evans ZP; Atkinson C; Schmidt MG; Schnellmann RG; Chavin KD
    Liver Transpl; 2009 Sep; 15(9):1101-9. PubMed ID: 19718644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
    Kato H; Kuriyama N; Duarte S; Clavien PA; Busuttil RW; Coito AJ
    J Hepatol; 2014 May; 60(5):1032-9. PubMed ID: 24412604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbated ischemia-reperfusion injury in fatty livers is mediated by lipid peroxidation stress and ferroptosis.
    Rokop ZP; Zhang W; Ghosh N; Biswas N; Das A; Lin J; Sen CK; Kubal C
    Surgery; 2024 Jun; 175(6):1539-1546. PubMed ID: 38508920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
    Arrenberg P; Maricic I; Kumar V
    Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of L-selectin-guided CD8
    Kolachala VL; Palle S; Shen M; Feng A; Shayakhmetov D; Gupta NA
    Hepatology; 2017 Oct; 66(4):1258-1274. PubMed ID: 28543181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver.
    Gupta NA; Kolachala VL; Jiang R; Abramowsky C; Shenoi A; Kosters A; Pavuluri H; Anania F; Kirk AD
    Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1088-99. PubMed ID: 25258410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.
    Liss KHH; McCommis KS; Chambers KT; Pietka TA; Schweitzer GG; Park SL; Nalbantoglu I; Weinheimer CJ; Hall AM; Finck BN
    Liver Transpl; 2018 Jul; 24(7):908-921. PubMed ID: 29729104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis.
    Fusai G; Glantzounis GK; Hafez T; Yang W; Quaglia A; Sheth H; Kanoria S; Parkes H; Seifalian A; Davidson BR
    Clin Sci (Lond); 2005 Nov; 109(5):465-73. PubMed ID: 15982189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
    Shaker ME; Trawick BN; Mehal WZ
    Biochem Pharmacol; 2016 Jul; 112():90-101. PubMed ID: 27157410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary alpha- and gamma-tocopherol (1:5 ratio) supplementation attenuates adipose tissue expansion, hepatic steatosis, and expression of inflammatory markers in a high-fat-diet-fed murine model.
    Juretić N; Sepúlveda R; D'Espessailles A; Vera DB; Cadagan C; de Miguel M; González-Mañán D; Tapia G
    Nutrition; 2021 May; 85():111139. PubMed ID: 33549947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.
    Chu MJ; Premkumar R; Hickey AJ; Jiang Y; Delahunt B; Phillips AR; Bartlett AS
    World J Gastroenterol; 2016 May; 22(19):4673-84. PubMed ID: 27217699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver.
    Fujii T; Kuriyama N; Hayasaki A; Iizawa Y; Tanemura A; Kato H; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2018 Nov; 50(9):2807-2814. PubMed ID: 30401402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia reperfusion injury induces pyroptosis and mediates injury in steatotic liver thorough Caspase 1 activation.
    Kolachala VL; Lopez C; Shen M; Shayakhmetov D; Gupta NA
    Apoptosis; 2021 Jun; 26(5-6):361-370. PubMed ID: 33990906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
    Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
    Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term N-acetylcysteine administration rescues liver steatosis via endoplasmic reticulum stress with unfolded protein response in mice.
    Tsai CC; Chen YJ; Yu HR; Huang LT; Tain YL; Lin IC; Sheen JM; Wang PW; Tiao MM
    Lipids Health Dis; 2020 May; 19(1):105. PubMed ID: 32450865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.